Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 2242
MIM: 190030
HGNC: 3657
Ensembl: ENSG00000182511
Variants:
dbSNP: 2242
ClinVar: 2242
TCGA: ENSG00000182511
COSMIC: FES
RNA/Proteins
Expression (GTEx)
Pathways
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36321446 | 2022 | The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis. | 12 |
| 36321446 | 2022 | The FES Gene at the 15q26 Coronary-Artery-Disease Locus Inhibits Atherosclerosis. | 12 |
| 31573955 | 2020 | Identification of FES as a Novel Radiosensitizing Target in Human Cancers. | 2 |
| 31746983 | 2020 | FER and FES tyrosine kinase fusions in follicular T-cell lymphoma. | 8 |
| 31573955 | 2020 | Identification of FES as a Novel Radiosensitizing Target in Human Cancers. | 2 |
| 31746983 | 2020 | FER and FES tyrosine kinase fusions in follicular T-cell lymphoma. | 8 |
| 23404507 | 2013 | A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells. | 11 |
| 23404507 | 2013 | A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells. | 11 |
| 19865112 | 2010 | Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. | 45 |
| 20117079 | 2010 | FES kinase participates in KIT-ligand induced chemotaxis. | 2 |
| 20628086 | 2010 | Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. | 15 |
| 19865112 | 2010 | Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias. | 45 |
| 20117079 | 2010 | FES kinase participates in KIT-ligand induced chemotaxis. | 2 |
| 20628086 | 2010 | Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. | 15 |
| 19001085 | 2009 | Contributions of F-BAR and SH2 domains of Fes protein tyrosine kinase for coupling to the FcepsilonRI pathway in mast cells. | 13 |
Citation
Dessen P
FES (FES proto-oncogene, tyrosine kinase)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/40546/fes
